403 POSTER Clinical responses in highly refractory solid tumor patients with oral MP-470, a multi-targeted tyrosine kinase inhibitor, in combination with standard of care chemotherapy regimens: preliminary report from a multi-institutional phase-1b clinical trial
A.W. Tolcher, M. Mita, M. Gordon, L. Rosen, A. Patnaik, G.D. Fine, G.S. Choy, G.I. BerkVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72337-1
File:
PDF, 78 KB
english, 2008